Microbiome Applications - Market Research, Industry Trends, Market Share


Published: 12/06/2017
Pages: 280
Full Study Price: US$ 1,500

The term 'microbiome' refers to the human body's community of microorganisms, and researchers are increasingly considering the microbiome's relationship with its human host to be crucial to overall health. Human Microbiome Applications in IVD and Other Healthcare examines researchers' growing ineterst in the human microbiome within the context of in vitro diagnostics applications, and touches on areas such as metagenomics, metabolomic profiling, microbiome diagnostics, and more.

Human Microbiome Applications in IVD and Other Healthcare also touches on pharmaceutical companies' interest in the microbiome, which has been spurred on by the human microbiome project. Within the microbiome market, competitors are amassing data on the microbiome in order to partner with pharmaceutical firms that have an interest in the development of new therapeutics. This report discusses microbiome-based therapeutic approaches, as well as current microbiome-related drug candidates.

Human Microbiome Applications in IVD and Other Healthcare also profiles the many competitors in the microbiome market that are involved in testing, therapeutics, sample preparation and processing, and more. Microbiome companies and start-ups offer many products and services which are discussed in the report. Information in this report is drawn from data gathered from government reports, company product literature and other corporate brochures and documents, and information drawn from the scientific and trade press.

Our Simple Buying Process

Choose License and Add
This Report To Your Cart.

Register, Checkout
and Verify Payment.

Receive Notification When
Your Report Is Available.

Table Of Contents

  • Executive Summary
    • Introduction
    • Large-Scale Microbiome Projects
    • Scope of the Report
    • Methodology
  • Human Microbiome in IVD and Other Healthcare Applications
    • Microbiome - Bacteria in Disease Processes
    • Growing Interest in the Microbiome
    • Metagenomics
    • Metabolomic Profiling
    • Microbiome Diagnostics
      • Table Selected Microbiome-based Tests
      • Selected Molecular Microbiome-based Tests
      • Diagnostic Biomarkers
      • Precision or Personalized Medicine Approaches
    • Pharma Company Interest in the Microbiome
      • Agreements, Investments
      • Fecal Microbiota Transplantation (FMT)
      • Other Selected Microbiome-related Therapeutic Approaches
      • Microbiome Modulators
    • Investment in Microbiome Companies
      • Table Selected Investments in Microbiome Companies
  • Selected Microbiome Players
    • 4D Pharma plc
      • GT Biologics
    • Abbott Diagnostics
      • Company Overview
      • IRIDICA
      • The Microbiome Coalition
    • Abbvie
      • Synlogic Partnership
    • Aces Health
    • AdvancingBio
    • Agilent Technologies Inc.
    • Anaeropharma Science
    • AOBiome, LLC
    • Aperiomics, Inc.
    • Arivale
    • Atlas Biomed
    • AvidBiotics
      • Pylum Biosciences, Inc.: Microbiome-focused Company with Precision Anti-Bacterial Technology
      • Xyphos, Inc.: Immuno-Oncology Focused Company with Flexible CAR-T Technology
    • Beckman Coulter / Danaher
    • Becton, Dickinson and Company (BD)
      • Cytology
      • BD Max Molecular
      • ID/AST
      • POC Veritor
      • Mass Spectrometry
      • Blood Collection
      • Flow Cytometry
      • Licensing
    • Biocartis Group
      • Microbiome
      • Company Overview
    • The BioCollective
    • BioGaia Pharma AB
    • Biohit OYJ
      • Microbiome
      • Company Overview
      • Market Expansion
    • Biomecite Diagnostics
    • bioMĂ©rieux Inc.
      • Traditional Microbiology
      • Blood Culture
      • Immunoassays
      • Mass Spectrometry
      • Platelet Safety
      • Sequencing
      • Sequencing - Sample Preparation, Molecular
      • Data Analysis
      • BioFire Diagnostics Business
    • Bio-Rad Laboratories, Inc.
      • Microbiome
      • Company Overview
      • Quality Control
      • Blood Bank
      • Infectious Diseases - Molecular
      • Immunoassays
      • Liquid Biopsy
      • Droplet Digital PCR
      • Sequencing
    • biose
    • Blis Technologies
    • Bruker Corporation
      • Microbiome
      • Company Overview
    • C3J Therapeutics (formerly C3 Jian)
    • Capsugel
    • Charles River Laboratories, Inc.
      • Microbiome
      • History and Lines of Business
      • Drug Discovery Services
    • CIPAC Therapeutics
    • CLC bio (a QIAGEN company)
    • Clinical-Microbiomics
    • Copan Diagnostics, Inc.
      • Lab Automation
      • Partnerships
      • Swabs
    • CosmosID
    • Covaris
      • Sample Prep for Microbiome Research
      • Company Overview
    • Crestovo (Finch Therapeutics Group)
    • Danaher Corporation
      • Company Overview
      • Mass Spectrometry
      • Danaher Buys Phenomenex
    • Dermala
    • DermTech
    • Diversigen
    • DNA Genotek
    • DNAnexus, Inc.
    • Eagle Genomics
    • Eligo Bioscience
    • ENTEROME Bioscience SA
      • Bristol-Myers Squibb
      • Vertex Pharmaceuticals
      • Takeda Pharmaceutical
      • Janssen Biotech
      • Nestle Health Science
    • EpiBiome
      • Company Overview
    • Partnerships and Collaborations
    • Eppendorf AG
    • Evelo Biosciences
    • Evolve Biosystems
    • Finch Therapeutics Group
    • GALT
    • GATC Biotech AG
    • Genetic Analysis AS
      • Company Overview
      • Agreement with Bio-Rad
    • GENEWIZ, Inc.
    • GlaxoSmithKline plc
      • Company Overview
      • Microbiome-related Developments
    • Human Longevity, Inc. (HLI)
    • Illumina
      • Sequencing
      • Microbiome-related Developments
    • IS-Diagnostics
    • ISOThrive LLC
    • Janssen Biotech (Johnson & Johnson)
      • The Janssen Human Microbiome Institute (JHMI)
        • Table Janssen Human Microbiome Institute (JHMI), Already Existing Microbiome Collaborations with Biotechnology Companies and Academic Institutions, February 2015
      • MOSAIC Microbiome Platform
      • License Agreement with Vedanta Biosciences
    • Kallyope
    • Labcyte
    • Luminex Corporation
      • Microbiome-related Developments
      • Company Overview
      • Assay Development
      • Verigene Business
      • Business Expansion
    • Mayo Medical Laboratories
    • Menarini-Silicon Biosystems
    • Merck & Co., Inc.
    • Metabiomics Corporation
    • MetaboGen AB
    • Metabolon, Inc.
      • Company Overview
      • Precision Metabolomics
      • Partnerships and Collaborations
    • Microbiome
    • Microbiome Insights
    • MicroBiome Therapeutics (MBT)
      • Company Overview
      • Technology
    • Mitra Biotech
    • MyBiotics
    • Naked Biome
    • NestlĂ© Health Science
      • Company Overview
      • Microbiome-related Development
    • New England Biolabs
      • Company Overview
      • Microbiome-related Development
    • Nizo
    • Norgen Biotek
    • OncoImmunity
    • One Codex
      • Company Overview
      • Microbiome-related Development
    • OpenBiome
      • Company Overview
      • Finch Therapeutics
    • Optibiotix
      • Company Overview
      • Technology Platforms
    • OraSure Technologies, Inc.
      • Company Overview
      • The Genotek Business
    • Osel, Inc.
      • Company Overview
      • Portfolio
    • PerkinElmer, Inc. (PE)
      • Company Overview
      • Diagnostics
      • Sample Prep
      • Sequencing
      • Histology
      • Prenatal Business
      • Lab Services
      • Expansion
    • Pfizer, Inc.
    • Phase Genomics
    • Proderm IQ
    • Prodigest
    • Promega Corporation
    • PureFlora Inc.
    • QIAGEN
      • QIAGEN Bioinformatics
    • Quay Pharma
    • Rebiotix
    • Resphera Biosciences
    • Ritter Pharmaceuticals, Inc.
      • Company Overview
      • RP-G28
    • Roche Diagnostics
      • Company Overview
      • Microbiome-related Developments
    • Sabinsa Corporation
    • ScreenCell
    • Second Genome
    • Seres Therapeutics
      • Collaboration with The University of Texas MD Anderson Cancer Center and the Parker Institute for Cancer Immunotherapy
      • Biotherapies for Infection Treatment
      • Selected Products in Development
    • Shimadzu Corporation
    • Siolta Therapeutics
    • Symbiotic Health
    • SynCo Bio Partners B.V.
    • Synlogic
      • Company Overview
      • AbbVie Partnership
    • Synthetic Biologics
      • Company Overview
      • SYN-004 (ribaxamase)
      • SYN-010
    • Thermo Fisher Scientific, Inc.
      • Microbiome-related Development
      • Company Overview
    • TNO
    • Triskelion
    • uBiome
    • Vaiomer
    • Vedanta Biosciences
    • VIOME
    • ViThera Pharmaceuticals
    • Waters Corporation
    • Whole Biome
    • Xycrobe Therapeutics, Inc.
      • Company Overview
      • Research Agreement with Johnson & Johnson Consumer
    • Zymo Research